Running title: Identification of herbal compatibility mechanisms with transcriptome data
Introduction
At present many complex and chronic diseases rely on therapies that combine modern pharmaceuticals. A similar multiple-herb strategy known as "Fufang" is an essential component in traditional Chinese medicine (TCM) theory and is used to achieve better therapeutic results, and reduce side effects and herbal toxicity 1 -2 . As result of thousands of years' of accumulated clinical practice, TCM has more than 100,000 formulae and abundant experience that has contributed to an understanding of which herbs should be combined in particular circumstances, herein referred to as herbal compatibility 3, 4 . However, because herbal medicines are made up of complex mixtures of plant secondary metabolites, the mechanism of most TCM formulas has not been explored. This limitation of TCM has become one of the key problems for its modernization, and hinders the application and popularization of herbal medicines 5 .
Recent rapid developments in analytical chemistry and molecular biology have provided methods for researchers to tackle the complex mechanisms of herbal compatibility on a number of different levels. Usually, these methods focus on one or a few components within a complex mixture, in attempts to reveal how preparation/extraction for combined use can change their concentrations in products or pharmacokinetic processes in vivo [6] [7] [8] [9] . However, as a complex mixture may contain thousands of compounds, it is unclear how changing one or several components in a TCM formula can explain and account for the principles and observations of herbal compatibility. Furthermore, pharmacological models that measure phenotypes associated with efficacy or proxies for efficacy are limited in their ability to explain potential therapeutic effects and mechanisms. New high-throughput technologies for measuring molecular phenotypes such as gene expression, and bioinformatic methods can provide systematic ways for refining and clarifying complex biological processes that result from hundreds or thousands of molecular interactions. By applying these methods to the study of TCM, it is possible to transform the research paradigm from "main active compound that influences one target" to "multiple components that influence many network targets" 10, 11 .
Although it is now common to apply RNA-sequencing and systematic methods to study the effects of whole TCM formulae, no literature has applied these methods to study herbal compatibility. In this report, we apply transcriptome analysis to identify how the combination of Kushen ( Sophorae flavescentis ) and Baituling ( Heterosmilax yunnanensis Gagnep ) extracts can account for the broader and increased effects observed in Compound Kushen Injection (CKI).
Our model system for dissecting herbal compatibility, CKI, is derived from an ancient Chinese formula and was approved by the State Food and Drug Administration (SFDA) of China in 1995.
It is widely used as an adjuvant medicine in the treatment of carcinomas for pain relief, activation of innate immune response and reduced side effects in cancer therapy 12, 13 . Our previous results have shown that CKI suppresses the growth of cancer cells by inhibiting cell cycle, energy metabolism, and DNA repair pathways 11, 14 . Kushen is considered to be the principal herb and major contributor to the molecular effects of CKI. Many published studies have reported on the alkaloids and flavonoids contained in CKI, most of which are extracted from Kushen. These compounds have been reported to have a variety of bioactivities, including antitumor, antioxidant and anti-inflammatory activities 15, 16 . However, there is no literature that mentions the role of Baituling in CKI. Therefore, current studies are not sufficient to provide a rational framework for CKI prescription or explain its molecular mechanisms.
In this report, we break down the formula into its individual components in order to study the herbal compatibility of CKI. By comparing transcriptome changes in MDA-MB-231 cells between CKI and single herbal extract treatments, we found that Kushen extract alone, perturbed most of the pathways through which CKI exerts its effects on cancer cells. However, integrating Kushen with Baituling can enhance the effects of Kushen alone on cancer-related pathways and in addition can activate innate immune functions. These results support the TCM rationale behind the CKI formula and confirm RNA-sequencing as a useful tool for the identification of candidate mechanisms in TCM research.
Results

HPLC comparison of the composition of CKI and single extract injections.
In order to obtain information about plant specific components in CKI, we used high-performance liquid chromatography (HPLC) to compare the compounds in CKI and two single herb extracts/injections ( Fig.1 ). From the chromatographic profile, it can be seen that Kushen injection contributes most of the major chemical components in CKI. In contrast, few compounds were detected in Baituling injection, which only contributes one major compound to CKI. Based on comparison with 9 reference standard compounds, 8 main compounds derived from Kushen (adenine, N-methylcytisine, sophorodine, matrine, sophocarpine, oxysophocarpine, oxymatrine and trifolirhizin) are shown to contribute to CKI. Macrozamin, which is used as a control marker for Baituling during manufacturing, only appeared in CKI and Baituling injection. These results indicate that CKI contains major compounds from both Kushen and Baituling, and Kushen contributes most of the major chemical components in CKI.
Comparison of the anticancer effects between CKI and single injections.
Our previous results showed CKI suppressed the proliferation of and induced apoptosis in MCF-7 cells 11 . To determine whether single injections had similar phenotypic effects as CKI, we conducted XTT assays to measure cell viability using three different cell lines; MDA-MB-231, A431 and HepG2. Results showed that Kushen had stronger cytotoxic effects than Baituling in all three cell lines. However, neither of the single injections had apoptotic effects comparable to CKI ( Fig.2A ) based on rates of apoptosis determined by flow cytometry with propidium iodide (PI) staining. Consistent with XTT cell viability results, more apoptotic cells were found in CKI treatments than single injections and BTL had the smallest effect on apoptosis of the three injections ( Fig.2B ).
Comparison of MDA-MB-231 transcriptomes from CKI and single injection treatments.
In order to elucidate the molecular mechanisms of herbal compatibility in CKI, we carried out transcriptome profiling from CKI and single injection treated MDA-MB-231 cells. Triplicate samples for each treatment clustered well in multidimensional scaling plots and different treatments were clearly separated ( Supplementary Fig 1) . Although CKI and Kushen injection have similar chemical profiles, the inclusion of Baituling in CKI is sufficient to change the transcriptome of MDA-MB-231 cells compared to Kushen single injection treatment. We used edgeR 17 to identify differentially expressed (DE) genes for each injection treatment compared to untreated. In addition, we also identified DE genes for CKI treatment compared to Kushen treatment to identify the effects of Baituling in CKI ( Supplementary Table 3 ).
To validate the results of transcriptome analysis, we performed quantitative PCR for several genes known to be important read-outs for the effects of CKI; TP53, CYD1A1 and CCND1.
Their expression levels confirmed the interaction of Baituling with Kushen observed in the overall RNA sequencing results ( Fig.2C ).
Similar effects of CKI and Kushen single injection on MDA-MB-231 cells.
Because Kushen is considered to be the primary active herb in CKI, we first examined the effects of Kushen and CKI to see if they had similar effects on genes. By comparing the DE gene set between Kushen and CKI, the shared DE gene group accounted for 63% and 81% of DE genes from CKI and Kushen respectively ( Fig.3A) , indicating that Kushen contributed to the majority of effects from CKI.
In order to better understand the functions of shared DE genes between Kushen and CKI, we performed over-representation analysis using Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways for these 2039 genes( Fig.3B&C , Supplementary Table   5 ). The results showed that cell cycle-and DNA replication-related pathways and terms were largely down-regulated by both Kushen and CKI. Based on our previous publications, perturbed regulation of genes in these pathways and annotated by these terms was associated with the observed cell viability and apoptotic effects CKI on cancer cells 11, 14 . Other terms showing perturbation of metabolic processes and cell migration identified in this study, such as 'pyrimidine metabolism', 'steroid biosynthesis' and 'positive regulation of locomotion', also showed up in our previous research on the effects of CKI. Altogether, these results indicated that Kushen was very important to the major molecular consequences of CKI treatment, and perturbed most of the functions perturbed by CKI, including reduced viability and apoptosis in cancer cells.
Different effects of CKI and single injections on MDA-MB-231 cells
Although the above results for enrichment analysis showed that Kushen and CKI mainly regulate the same pathways, they did not specifically show the magnitude and direction of these perturbations. We, therefore, performed Signalling Pathway Impact Analysis (SPIA) to compare the significantly perturbed functional pathways across the different treatments. Ninety two pathways were found to be significantly perturbed by CKI while only 30 of them were shown to be activated. For Kushen and Baituling, the ratios of activated/inhibited were 29/100 and 24/58 respectively ( Supplementary Table 4 ). Clearly, Baituling perturbed fewer pathways, but the ratio of activated/inhibited was higher than for Kushen or CKI. Interestingly, most pathways were perturbed in the same way (inhibited or activated) by CKI and Kushen as shown in Fig.4A , with very few pathways showing different types of perturbation .
This similarity of effects between Kushen and CKI could also be seen in the high level of correlation for pathway perturbation between Kushen and CKI (0.83 correlation coefficient) compared to (0.33 correlation coefficient) for Baituling and CKI. CKI also had stronger perturbation effects on most pathways ( Fig.4C ). In pathways contributing to cytotoxic effects in cancer cells, such as cell cycle, p53 signaling pathway, proteoglycans in cancer and pathways in cancer, Baituling perturbed the pathways in the same direction as Kushen and seemed to reinforce those effects in CKI. However, the cytokine-cytokine receptor interaction pathway was very interesting as it was perturbed in an opposite fashion in Baituling compared to Kushen and did not show up as significantly perturbed by CKI treatment ( Supplementary Fig. 2 ) . By comparing DE genes for Baituling and Kushen in the cytokine-cytokine receptor interaction pathway ( Fig.5 ), we observed that many genes were oppositely regulated by the two single injections, such as genes in the CXC subfamily and IL6/12-like cytokine and receptor genes, which supported the SPIA results.
The functions of Baituling in CKI.
In order to investigate the function of Baituling in CKI, we identified the DE genes of CKI treatment compare to Kushen treatment. Only 308 DE genes were found (Fig.6A ). KEGG analysis of these genes showed that with the exception of steroid hormone biosynthesis and transcriptional misregulation in cancer, all other pathways were related to immune function, and most genes in this set were up-regulated ( Fig.6B , Supplementary Table 5 ). This result was consistent with findings in the SPIA analysis that Baituling tended to activate immune-related pathways. The over-represented GO terms for this gene set also included interferon-gamma production, organ or tissue specific immune response and interleukin-2 production, all aspects of immune function and which only contained up-regulated DE genes (Fig.6C) .
The genes in the common set between Kushen and CKI compared to Kushen (Fig. 6A ) were originally changed with Kushen treatment and then further significantly regulated in combination with Baituling (107 genes). Only three pathways (IL-17 signaling, salmonella infection and steroid hormone biosynthesis) were over-expressed by genes in this set, indicating Baituling could also modify functions related to immune system and hormone function upregulated by Kushen in CKI ( Supplementary Fig 3 . ). Furthermore, 24 genes appeared in both Baituling and CKI sets compared to the Kushen set ( Fig. 6A) , which can be regarded as the direct contribution from Baituling to the effects of CKI. Analysis of known protein-protein interactions in this gene set identified the IL-1 family and interacting proteins known to modulate immune function ( Fig.7A ). To verify that IL-1 protein levels were also changing as predicted, we carried out an ELISA assay to measure the IL-1 beta levels in different treatments. We were able to demonstrate that the increased IL-1 beta level in CKI treatment compared to untreated was mainly related to the effects of Baituling (Fig.7B ). Altogether, these results showed that Baituling contributed to the effects of CKI primarily by altering functions related to the immune system.
In summary, we characterized the herbal compatibility of Kushen and Baitulin in CKI by comparing the individual effects of the herbal extracts to the combined extract using transcriptome analysis. In this fashion, we were able to explain the origin of CKI's different effects in MDA-MB-231 cells. In addition, we also showed that Baituling could enhance the reduction of cell viability and increased apoptosis effects from Kushen in CKI. These results not only explained the specific molecular basis of the TCM rationale of combining Kushen with Baituling but also illustrate a general method to apply transcriptome analysis to study herbal compatibility in TCM.
Discussion
It is undeniable that chemical composition is the basis of therapeutic effects from herbal TCM.
However, because the identification and quantification of all compounds for even a single herb are still extremely difficult if not impossible, we need alternative means to conduct TCM research, particularly with respect to the study of herbal compatibility 18, 19 . Herbal compatibility has a basis in TCM theory, but TCM theory is not generally accepted in Western medicine and it is difficult to map concepts from TCM theory to Western medicine. Methods that can identify the molecular consequences of TCM formulations and individual herbs can begin to provide such a map. One view of TCM is that it perturbs multiple targets or pathways with multiple low activity components to generate relatively strong effects. This is in contrast to the standard approach for pharmaceutical drug development which seeks to identify single compounds that inhibit a single pathway or target. However, this method of using one or several active compounds as representative of single herbs is problematic 10 for understanding the roles of individual plant extracts in TCM formulations. This is illustrated by our results; although containing similar amounts of the main chemical compounds, CKI has much stronger effects than Kushen extract alone. Therefore, a formula disassembly approach that uses single herbs is a practical way to study herbal compatibility. Combined with omics techniques and network analysis, we can represent the mechanisms of TCM herbal compatibility as interactions between target networks familiar to Western medicine. In this report, we took CKI, a prescription containing only two herbs, as a proof of principle. However, related methods can easily be applied to more complex formulae.
As a frequently used herb, and because it is considered to contain the main bioactive components in CKI, Kushen or its main alkaloids and flavonoids are commonly used to represent CKI in studies 20, 21 . Furthermore, TCM theory also regards Kushen as the primary herb in CKI. Our results support these hypotheses and TCM theory at different levels. First, at the chemical level, HPLC profiles showed that the source of most major components in CKI is Kushen. Second, in terms of overall efficacy, Kushen has much stronger cytotoxic effects than Baituling on various cell lines. Third, at the gene level, DE genes shared by Kushen and CKI account for 81% and 63% of total DE genes in Kushen and CKI treatments, and most of them are consistently up-or down-regulated. Furthermore, important genes are also regulated both by Kushen and CKI. Cytochrome P450 family 1 subfamily A member 1 (CYP1A1) gene, a steroid metabolizing enzyme which is important for steroid hormone responsive cancers and shown as the most over-expressed gene with CKI in our previous results, is also highly overexpressed by Kushen but not Baituling 22, 23 . Also, the down-regulation of the TP53 gene primarily results from Kushen. Our previously results based on CKI observed cells underwent apoptosis while expression of TP53 decreased, which indicates the apoptosis induced by Kushen and CKI is not TP53 -dependent 11 . Finally, GO and KEGG over-representation analysis also indicated that the genes in major cancer related pathways and terms perturbed by CKI including cell cycle, DNA replication, and cell migration, are induced by the shared DE gene set between Kushen and CKI. Taken together, our findings agree with TCM theory which considers Kushen as the principle herb in CKI, and they map this specific part of TCM theory to effects on specific genetic networks and pathways.
On the other hand, we could find no Baituling literature and studies on macrozamin to support its application in CKI 24 . From our HPLC and cytotoxic assay results, Baituling injection does not contain many components and has no significant effects on cancer cells. In addition, NAseq analysis of Baituling-treated samples are close to the untreated samples in the multidimensional scaling plot, and only 253 DE genes compared to untreated were detected. However, after comparing the differences between CKI and Kushen, we found Baituling has a strong reinforcing effects on Kushen. The SPIA results showed Baituling can enhance many pathways' perturbation strength compared to Kushen treatment, including cell cycle, pathways in cancer and proteoglycans in cancer. In addition, many DE genes in immune-related pathways and GO terms are over-represented in CKI compared to Kushen. Together with the opposing direction of perturbation for the cytokine-cytokine receptor interaction pathway caused by Kushen and Baituling, we can conclude Baituling may also contribute to the immune regulatory effects of CKI. This was confirmed by our measurements of IL-1 , which was significantly up-regulated by Baituling and CKI. In conclusion, our results indicate that Baituling, an adjuvant herb in CKI according to TCM theory, may enhance the anticancer effects of Kushen and contribute to immune regulation.
In conclusion, we explained the TCM herbal compatibility of CKI in the context of pathway perturbations using transcriptome analysis. Kushen primarily contributes to CKI effects on cancer cells by perturbing cell cycle regulation and other functions 11, 14 , meanwhile, Baituling enhanced potential anticancer effects for Kushen and activated the immune system. Therefore, the two herbs in CKI collaborate with differences in effects, which is very similar to formulation theory in TCM. Compared to previous studies on herbal compatibility, our method can explain the beneficial interaction pattern of herbs in TCM formulae in a more systematic and comprehensive fashion.
Methods
Cell culture and drugs
MDA-MB-231, HepG2 and A431 cells were purchased from ATCC (VA, USA). All cell lines were cultured at 37℃ with 5% CO 2 in DMEM (Thermo Fisher Scientific, MA, USA) with 10% fetal bovine serum (Thermo Fisher Scientific). CKI, Baituling, and Kushen injections were provided by Zhendong pharmaceutical Co.Ltd (China). Baituling and Kushen injections were manufactured using the same processes as CKI and diluted to the equivalent concentration of CKI (total alkaloid concentration at 2 mg/ml).
All in vitro assays were conducted in 6-well or 96-well plates. The seeding density was 4 × 10 5 
Cell viability assay
Cells were cultured and treated in 96-well plates. After 48 hours drug treatment, 50 μl of XTT:PMS (at 1 mg/ml and 1.25 mM, respectively, and combined at 50:1 ratio, Sigma-Aldrich, MO, USA) was added into each well and incubated 4 hours for the measurement of cell viability.
A Biotrack II microplate reader was used to detect the absorbance at 492 nm.
Apoptosis rate with cell cycle assay
After treatment, cells were harvested from 6-well plates and stained with propidium iodide (PI;
Sigma-Aldrich) as previously described 25 . The stained cells were quantified on a BD LSR Fortessa-X20 (BD Biosciences, NJ, USA) and the data were analyzed with FlowJo software (TreeStar Inc., OR, USA).
qPCR for transcriptome validation
The assay was performed as previously described 11 . The sequences of all primers are shown in the Supplementary Table. RNA extraction and sequencing 
Transcriptome data analysis
The adaptors and low-quality sequences in raw reads were trimmed with Trim_galore (v0.3.7, Babraham Bioinformatics) using parameters: --stringency 5 --paired. STAR (v2.5.3a) was used to align reads to reference genome (hg19, UCSC) with parameters: --outSAMstrandField intronMotif --outSAMattributes All --outFilterMismatchNmax 10 --seedSearchStartLmax 30 26 .
Differentially expressed genes were calculated with edgeR (v3.22.3) and selected with false discovery rate (FDR) < 0.05 and Log fold change >1 or <-1 17 .
The GO and KEGG over-representation analyses were performed with ClueGO and visualized with Cytoscape v3.6.0 with following parameters: right-sided hypergeometric test for enrichment analysis; p values were corrected for multiple testing according to the Benjamini-Hochberg method and biological process at 3rd level for GO terms 27, 28 . The Signalling Pathway Impact Analysis (SPIA) package in R was used to conduct the pathway perturbation analysis using all DE genes(FDR<0.05) 29 . R Pathview package was used to visualize specific KEGG pathways 30 .
String (V11.0) was used to identify protein-protein interactions with a threshold of 0.4 for minimum interaction score 31 . Table on the right-bottom corner shows the correlation coefficients for the perturbation value for the three injections. "*" and "***" represent p<0.05 and p< 0.001 respectively (Pearson's correlation test). 
ELISA for IL-1β level
